Correlation Between Septerna, Common and Dogwood Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Septerna, Common and Dogwood Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Septerna, Common and Dogwood Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Septerna, Common Stock and Dogwood Therapeutics,, you can compare the effects of market volatilities on Septerna, Common and Dogwood Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Septerna, Common with a short position of Dogwood Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Septerna, Common and Dogwood Therapeutics,.
Diversification Opportunities for Septerna, Common and Dogwood Therapeutics,
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Septerna, and Dogwood is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Septerna, Common Stock and Dogwood Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dogwood Therapeutics, and Septerna, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Septerna, Common Stock are associated (or correlated) with Dogwood Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dogwood Therapeutics, has no effect on the direction of Septerna, Common i.e., Septerna, Common and Dogwood Therapeutics, go up and down completely randomly.
Pair Corralation between Septerna, Common and Dogwood Therapeutics,
Given the investment horizon of 90 days Septerna, Common Stock is expected to generate 0.62 times more return on investment than Dogwood Therapeutics,. However, Septerna, Common Stock is 1.6 times less risky than Dogwood Therapeutics,. It trades about 0.15 of its potential returns per unit of risk. Dogwood Therapeutics, is currently generating about 0.03 per unit of risk. If you would invest 1,800 in Septerna, Common Stock on September 12, 2024 and sell it today you would earn a total of 501.00 from holding Septerna, Common Stock or generate 27.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 6.67% |
| Values | Daily Returns |
Septerna, Common Stock vs. Dogwood Therapeutics,
Performance |
| Timeline |
| Septerna, Common Stock |
| Dogwood Therapeutics, |
Septerna, Common and Dogwood Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Septerna, Common and Dogwood Therapeutics,
The main advantage of trading using opposite Septerna, Common and Dogwood Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Septerna, Common position performs unexpectedly, Dogwood Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will offset losses from the drop in Dogwood Therapeutics,'s long position.| Septerna, Common vs. Dogwood Therapeutics, | Septerna, Common vs. Viking Therapeutics | Septerna, Common vs. Vanda Pharmaceuticals | Septerna, Common vs. Verrica Pharmaceuticals |
| Dogwood Therapeutics, vs. Viking Therapeutics | Dogwood Therapeutics, vs. Vanda Pharmaceuticals | Dogwood Therapeutics, vs. Verrica Pharmaceuticals | Dogwood Therapeutics, vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |